News from pieris ag A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

04 Apr, 2012, 10:00 BST Pieris Presents Preclinical Data for PRS-110 c-Met Antagonist Anticalin® at the AACR Annual Meeting

--Results Support Differentiating Drug-like Features for Targeted Anti-cancer Drug-- Pieris AG announced today the presentation of a range of in...


07 Feb, 2012, 10:00 GMT Pieris Receives BMBF Grant to Fund PRS-110c-Met Antagonist Anticalin(R) Program

--Grant Supports Personalized Anti-Cancer Approach on Path to Clinic-- Pieris AG announced today the receipt of a EUR 1 million grant to support the...


13 Dec, 2011, 10:19 GMT Pieris Presents Preclinical Data for PRS-080 Hepcidin Antagonist Anticalin(R) Program at ASH Annual Meeting

-- Breadth of Pharmacokinetic Data Points to Tunable Half-life for Platform -- Pieris AG presented novel preclinical in vitro and in vivo data for...


15 Nov, 2011, 10:00 GMT Pieris Announces Results and Successful Completion of its PRS-050 Anticalin Phase I Trial at AACR-EORTC-NCI Molecular Targets and Cancer Therapeutics Conference

- Results Establish Safety, Tolerability, Lack of Immunogenicity and PK/PD Profile for First Anticalin in a Clinical Setting - Pieris AG presented...


19 Oct, 2011, 11:22 BST Pieris Outlines Strategic Impact of Six Million Euro EUROCALIN Grant Award on Anticalin® Pipeline Development

In concert with the award of the EU FP7 Grant to the Pieris-led EUROCALIN Consortium that will enable initial clinical development of Pieris'...


19 Oct, 2011, 10:48 BST EUROCALIN Consortium Initiates EU Grant Funded Collaboration to Develop Novel Anticalin Therapeutic to Treat Anemia

-- Consortium Will Receive Six Million Euro from Seventh Framework Programme -- The EUROCALIN Consortium, comprising 10 companies and universities...


23 May, 2011, 10:00 BST Pieris Announces Preclinical In Vitro and In Vivo Data for its Anticalin(r) PRS-080 Hepcidin Antagonist Drug Program

Pieris AG announced today preclinical in vitro and in vivo data for its PRS-080 Anticalin antagonist program targeting hepcidin, a small peptide...


12 Apr, 2011, 10:00 BST Pieris and Daiichi Sankyo Sign Therapeutic Collaboration to Develop Anticalin(R) Therapeutics

Pieris AG announced today the signature of a collaboration and license agreement with Daiichi Sankyo Company Limited (hereinafter Daiichi Sankyo;...


11 Apr, 2011, 10:00 BST Pieris to Present at BioCentury Future Leaders in the Biotech Industry Conference

Pieris AG announced today that Stephen Yoder, Chief Executive Officer, is scheduled to present at the 18th Annual BioCentury Future Leaders in the...


22 Feb, 2011, 09:00 GMT Pieris to Present Interim Data From the Phase I Clinical Trial of PRS-050 at Molecular Medicine Tri-Conference

Pieris AG announced today the upcoming presentation of new preclinical and interim Phase I clinical trial data for its PRS-050 Anticalin(r) program,...


10 Jan, 2011, 10:00 GMT Takeda San Francisco and Pieris Sign Anticalin(R) Therapeutic Collaboration

Takeda San Francisco (TSF) and Pieris AG have signed a drug discovery partnership agreement under which Pieris will apply its Anticalin(R) scaffold...